Pentamidine-loaded poly(D,L-lactide) nanoparticles: Physicochemical properties and stability work

International Journal of Pharmaceutics

Volumn 159, Issue 2, 1997, Pages 223-232

  Paul, M ^a   Fessi, H ^b   Laatiris, A ^a   Boulard, Y ^c   Durand, R ^d   Deniau, M ^d   Astier, A ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c Laboratoire de Biologie Parasitaire   (France)

^d FACULTÉ DE MÉDECINE   (France)

Author keywords

Nanoparticles; Pentamidine; Physicochemical properties; Poly(D,L lactide); Stability; Visceral leishmaniasis

Indexed keywords

DRUG CARRIER; LIPOID S 75; PENTAMIDINE; POLOXAMER; POLYGLACTIN; SYMPERONIC PE F 68; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED DRUG RELEASE; DRUG FORMULATION; DRUG STABILITY; DRUG TRANSPORT; LIPID COMPOSITION; PH; PRIORITY JOURNAL; VISCERAL LEISHMANIASIS;

EID: 0031574115     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00291-3     Document Type: Article

References (38)

1. Alving C.R., Steck E.A., Hanson W.L., Loizeaux P.S., Chapman W.L., Waits V.B. Improved therapy of experimental leishmaniasis by use of a liposome encapsulated antimonial drugs. Life Sci. 22:1978;1021-1026.
2. Alving C.R. Liposomes as drug carriers in leismaniasis and malaria. Parasitol. Today. 2:1986;101-107.
3. Berman J.D., Gallalee J.V., Williams J.S., Hockmeyer W.D. Activity of pentamidine-containing human red cell ghosts against visceral leishmaniasis in the hamster. Am. J. Trop. Med. Hyg. 35:1986;297-302.
4. Bazile D.V., Ropert C., Huve P., Verrecchia T., Marland M., Frydman A., Veillard M., Spenlehauer G. Bodydistribution of fully biodegradable 14C-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to rats. Biomaterials. 13:1992;1093-1102.
5. Coffin M.D., McGinity W. Biodegradable pseudolatexes: the chemical stability of poly(D,L-lactide) and poly(ε-caprolactone) nanoparticles in aqueous media. Pharm. Res. 9:1992;200-205.
6. Croft, S.L., Neal, R.A., Rao, L.S., Liposomes and other drug delivery systems in the treatment of leishmaniasis. In: Hart D.T. (Ed.), Leishmaniasis: The Current Status and New Strategies for Control. Plenum Press, New York, 1989, pp. 111-118.
7. Davidson R.N., Croft S.L., Scott A., Maini M., Moody A.H., Bryceson A.D.M. Liposomal amphotericin B in drug-resistant visceral leishmaniasis. Lancet. 337:1991;1061-1062.
8. Davidson R.N., Croft S.L. Recent advances in the treatment of visceral leishmaniasis. Trans. R. Soc. Trop. Med. 87:1993;130-131.
9. Davidson R.N., Di Martino L., Gradoni L., Giacchino R., Gaeta G.B., Pempinello R., Scotti S., Cascio A., Castagnola E., Maisto A., Gramiccia M., Caprio D.Di, Wilkinson R.J., Bryceson A.D.M. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (Ambisome). Clin. Infect. Dis. 22:1996;938-943.
10. Debs R.J., Brunette E.N., Lin J.M., Lin E.J., Montgomery A.B., Friend D.S., Pahahadjopoulos D.P. Selective enhancement of pentamidine uptake in the lung by aerosolization and delivery in liposomes. Am. Rev. Respir. Dis. 135:1987;731-737.
11. Deniau M., Durand R., Bories C., Paul M., Astier A., Couvreur P., Houin R. Etude in vitro de médicaments leishmanicides vectorisés. Ann. Parasitol. Hum. Comp. 68:1993;34-37.
12. Durand, R., Paul, M., Rivollet, D., Houin, R., Astier., A., Deniau, M., 1997. Activity of pentamidine-loaded methacrylate nanoparticles against Leishmania infantum in a mouse model. Int. J. Parasitol. 87(11), 1363-1367.
13. Fessi, H., Devissaguet, J.P., Puisieux, F., Thies, C., 1992. Process for preparation of dispersible colloidal systems of a substance in the form of nanoparticles, US Patent no. 5 118 528.
14. Fusaï T., Deniau M., Durand R., Bories C., Paul M., Rivollet D., Astier A., Houin R. Action of pentamidine bound nanoparticles against Leishmania on an in vivo model. Parasite. 1:1994;319-324.
15. Gaspar R., Préat V., Roland M. Nanoparticles of polyisohexylcyanoacrylate (PIHCA) as carriers of primaquine: formulation, physicochemical characterization and acute toxicity. Int. J. Pharm. 68:1991;111-119.
16. Gaspar R., Opperdoes F.R., Préat V., Roland M. Drug targeting with polyalkylcyanoacrylate nanoparticles: in vitro activity of primaquine-loaded nanoparticles against intracellular Leishmania donovani. Ann. Trop. Med. Parasitol. 86:1992;41-49.
17. Grizzi I., Garreau H., Li S., Vert M. Hydrolytic degradation of devices based on poly(D,L-lactic acid) size-dependence. Biomaterials. 16:1995;305-311.
18. Guterres S.S., Fessi H., Barrat G., Devissaguet J.P., Puisieux F. Poly(D,L-lactide) nanocapsules containing diclofenac: formulation and stability study. Int. J. Pharm. 113:1994;57-63.
19. Illum L., Khan M.A., Mak E., Davis S.S. Evaluation of carrier capacity and release characteristics for poly(butyl 2-cyanoacrylate) nanoparticles. Int. J. Pharm. 30:1986;17-28.
20. Kulkarni R.K., Pani K.C., Neuman C., Leonard F. Biodegradable poly(lactic acid) polymers. J. Biomed. Mater. Res. 5:1966;839-843.
21. Kulkarni R.K., Moore E.G., Hegyeli A.F., Leornarde F. Biodegradable poly(lactic acid) polymers. J. Biomed. Mater. Res. 5:1971;169-181.
22. Lemoine D., Francois C., Kedzierewicz F., Preat V., Hoffman M., Maincent P. Stability study of nanoparticles poly(ε-caprolactone), poly(D,L-lactide) and poly (D,L-lactide-co-glycolide). Biomaterials. 17:1996;2191-2197.
23. Lin W.J., Flanagan D.R., Linhardt R.J. Accelerated degradation of poly(ε-caprolactone) by organic amines. Pharm. Res. 11:1994;1030-1034.
24. Magenheim B., Benita S. Nanoparticle characterization: a comprehensive physicochemical approach. STP Pharm. Sci. 1:1991;221-241.
25. Makino K., Arakawa M., Kondo T. Preparation and in vitro degradation properties of polylactide microcapsules. Chem. Pharm. Bull. 33:1985;1195-1201.
26. Modabber, F., Leishmaniasis. In: Maurice, J., Pierce, A.M. (Eds.), Tropical Disease Research progress 91-92, 11th Program Report. World Health Organization, Geneva, 1992, pp. 77-81.
27. New R.R., Chance M.L. Treatement of experimental cutaneous leishmaniais by liposome-entrapped pentostam. Acta Trop. 37:1980;253-256.
28. Park T.G. Degradation of poply(lactic-co-glycolic acid) microspheres: effect of the copolymer composition. Biomaterials. 16:1995;1123-1130.
29. Paul, M., Durand, R, Boulard, Y., Fusaï, T., Fernandez, C., Rivollet, D., Deniau, M., Astier, A., 1997. Physicochemical characteristcs of pentamidine-loaded polymethacrylate nanoparticles: implication in the intracellular drug release in Leishmania major infected mice. J. Drug. Target.
30. Puisieux, F., Barrat, G., Couarraze, G., Couvreur, P., Devissaguet, J.P., Dubernet, C., Fattal, Y., Fessi, H., Vauthier, C., 1994. Polymeric micro and nanoparticles as drug carriers. In: Severian Dimitriu (Ed.), Polymeric Biomaterials. Marcel Dekker, New York, 1994, pp. 749-794.
31. Ritger P.L., Peppas N.A. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J. Control. Release. 5:1987;37-42.
32. Rodrigues J.M. Jr., Croft S.L., Fessi H., Bories C., Devissaguet J.Ph. The activity and ultrastructural localization of primaquine-loaded poly(D,L-lactide) nanoparticles in Leishmania donovani infected mice. Trop. Med. Parasitol. 45:1994;223-228.
33. Rodrigues J.M. Jr., Fessi H., Bories C., Puisieux F., Devissaguet J.Ph. Primaquine-loaded poly(lactide) nanoparticles: physicochemical study and acute tolerance in mice. Int. J. Pharm. 126:1995;253-260.
34. Rolland, A., 1987. Mise au point et applications de nanospheres á base de copolymères methacryliques. Intérêt pour la vectorisation d'agents cytostatiques (anthracyclines). Ph.D. Thesis, Université de Rennes, France.
35. Spenlehauer G., Vert M., Benoit J.P., Boddaert A. In vitro and in vivo degradation of poly(D,L-lactide/glycolide) type microspheres made by solvent evaporation method. Biomaterials. 10:1989;557-563.
36. Torre-Cisneros J., Villanueva J.L., Kindelan J.M., Jurado R., Sanchez-Guijo P. Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 17:1993;625-627.
37. Venier-Julienne M.C., Vouldoukis Monjour L., Benoit J.P. In vitro of the antileishmanial activity of biodegradable nanoparticles. J. Drug. Target. 3:1995;23-29.
38. Youssef M., Fattal E., Couvreur P., Adremont A. Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles. Antimicrob. Agents Chemother. 33:1988;1204-1207.